Tenax Therapeutics (TENX) Intangibles (2011 - 2017)
Tenax Therapeutics recorded quarterly Intangibles of $22.0 million in Q3 2017, little changed quarter-over-quarter from $22.0 million in Q4 2016, and little changed year-over-year from $22.0 million in Q3 2016.
Tenax Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $22.0 million for Q3 2017.
- In Q3 2017, Intangibles changed 0.0% year-over-year to $22.0 million; the TTM figure through Sep 2017 stood at $22.0 million (changed 0.0% YoY), while the FY2016 annual figure was $22.0 million, changed 0.0% from the prior year.
- Intangibles came in at $22.0 million for Q3 2017 at Tenax Therapeutics, roughly flat from $22.0 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $23.5 million in Q1 2015 to a low of $923397.0 in Q1 2013.
- A 5-year average of $17.2 million and a median of $22.0 million in 2015 frame the typical range for Intangibles.
- Across the five-year window, Intangibles soared 2434.6% in 2014 and decreased 6.14% in 2015, its largest moves.
- Tenax Therapeutics' Intangibles stood at $963810.0 in 2013, then surged by 2289.5% to $23.0 million in 2014, then slipped by 4.47% to $22.0 million in 2015, then changed by 0.0% to $22.0 million in 2016, then changed by 0.0% to $22.0 million in 2017.
- According to Business Quant data, Intangibles over the past three periods registered $22.0 million, $22.0 million, and $22.0 million for Q3 2017, Q4 2016, and Q3 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 22.00 Mn |
| Dec 31, 2016 | 22.00 Mn |
| Sep 30, 2016 | 22.00 Mn |
| Jun 30, 2016 | 22.00 Mn |
| Mar 31, 2016 | 22.00 Mn |
| Dec 31, 2015 | 22.00 Mn |
| Apr 30, 2015 | 22.00 Mn |
| Jan 31, 2015 | 23.53 Mn |
| Oct 31, 2014 | 23.03 Mn |
| Jul 31, 2014 | 23.45 Mn |
| Apr 30, 2014 | 23.44 Mn |
| Jan 31, 2014 | 23.40 Mn |
| Oct 31, 2013 | 963,810.00 |
| Jul 31, 2013 | 1.33 Mn |
| Apr 30, 2013 | 1.33 Mn |
| Jan 31, 2013 | 923,397.00 |
| Oct 31, 2012 | 904,498.00 |
| Jul 31, 2012 | 110,157.00 |
| Apr 30, 2012 | 872,971.00 |
| Jan 31, 2012 | 863,510.00 |
| Oct 31, 2011 | 831,407.00 |
| Jul 31, 2011 | 746,033.00 |
| Apr 30, 2011 | 699,951.00 |